NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 12, 2007, Pages 3116-3126

  Scott, Walter R P ^a   Baek, Seung Bin ^a   Jung, David ^a   Hancock, Robert E W ^a   Straus, Suzana K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Daptomycin; Lipopeptide; Mechanism of action; NOEs; Solution state NMR; Structure calculation

Indexed keywords

1,2 DIHEXANOYL SN GLYCERO 3 PHOSPHOCHOLINE; ANTIBIOTIC AGENT; BIOPOLYMER; CALCEIN; CALCIUM ION; DAPTOMYCIN; LIPOPEPTIDE; LIPOSOME; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIAL MEMBRANE; DRUG STRUCTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MODELS, MOLECULAR; PHOSPHOLIPID ETHERS;

BACTERIA (MICROORGANISMS);

EID: 36849002343     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.08.034     Document Type: Review

References (121)

1. Jung D., Rozek A., Okon M., and Hancock R.E.W. Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem. Biol. 11 (2004) 949-957
2. Rotondi K.S., and Gierasch L.M. A well-defined amphipathic conformation for the calcium-free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution. Biopolymers 80 (2005) 374-385
3. De Angelis A.A., Howell S.C., Nevzorov A.A., and Opella S.J. Structure determination of a membrane protein with two trans-membrane helices in aligned phospholipid bicelles by solid-state NMR spectroscopy. J. Am. Chem. Soc. 128 (2006) 12256-12267
4. Howell S.C., Mesleh M.F., and Opella S.J. NMR structure determination of a membrane protein with two transmembrane helices in micelles: MerF of the bacterial mercury detoxification system. Biochemistry 44 (2005) 5196-5206
5. Page R.C., Moore J.D., Nguyen H.B., Sharma M., Chase R., Gao F.P., Mobley C.K., Sanders C.R., Ma L., Sonnichsen F.D., Lee S., Howell S.C., Opella S.J., and Cross T.A. Comprehensive evaluation of solution nuclear magnetic resonance spectroscopy sample preparation for helical integral membrane proteins. J. Struct. Funct. Genomics 7 (2006) 51-64
6. Park S.H., De Angelis A.A., Nevzorov A.A., Wu C.H., and Opella S.J. Three-dimensional structure of the transmembrane domain of Vpu from HIV-1 in aligned phospholipid bicelles. Biophys. J. 91 (2006) 3032-3042
7. Park S.H., Prytulla S., De Angelis A.A., Brown J.M., Kiefer H., and Opella S.J. High-resolution NMR spectroscopy of a GPCR in aligned bicelles. J. Am. Chem. Soc. 128 (2006) 7402-7403
8. Franzin C.M., Gong X.M., Thai K., Yu J., and Marassi F.M. NMR of membrane proteins in micelles and bilayers: the FXYD family proteins. Methods 41 (2007) 398-408
9. Teriete P., Franzin C.M., Choi J., and Marassi F.M. Structure of the Na,K-ATPase regulatory protein FXYD1 in micelles. Biochemistry 46 (2007) 6774-6783
10. Hu J., Asbury T., Achuthan S., Li C., Bertram R., Quine J.R., Fu R., and Cross T.A. Backbone structure of the amantadine-blocked trans-membrane domain m2 proton channel from influenza a virus. Biophys. J. 92 (2007) 4335-4343
11. Li C., Gao P., Qin H., Chase R., Gor'kov P.L., Brey W.W., and Cross T.A. Uniformly aligned full-length membrane proteins in liquid crystalline bilayers for structural characterization. J. Am. Chem. Soc. 129 (2007) 5304-5305
12. Sanders C.R., and Sonnichsen F. Solution NMR of membrane proteins: practice and challenges. Magn. Reson. Chem. 44 (2006) S24-S40 (Spec No)
13. Chill J.H., Louis J.M., Baber J.L., and Bax A. Measurement of 15N relaxation in the detergent-solubilized tetrameric KcsA potassium channel. J. Biomol. NMR 36 (2006) 123-136
14. Hwang P.M., Choy W.Y., Lo E.I., Chen L., Forman-Kay J.D., Raetz C.R., Prive G.G., Bishop R.E., and Kay L.E. Solution structure and dynamics of the outer membrane enzyme PagP by NMR. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13560-13565
15. Andronesi O.C., Pfeifer J.R., Al-Momani L., Ozdirekcan S., Rijkers D.T., Angerstein B., Luca S., Koert U., Killian J.A., and Baldus M. Probing membrane protein orientation and structure using fast magic-angle-spinning solid-state NMR. J. Biomol. NMR 30 (2004) 253-265
16. Etzkorn M., Martell S., Andronesi O.C., Seidel K., Engelhard M., and Baldus M. Secondary structure, dynamics, and topology of a seven-helix receptor in native membranes, studied by solid-state NMR spectroscopy. Angew. Chem., Int. Ed. Engl. 46 (2007) 459-462
17. Lange A., Giller K., Pongs O., Becker S., and Baldus M. Two-dimensional solid-state NMR applied to a chimeric potassium channel. J. Recept. Signal Transduct. Res. 26 (2006) 379-393
18. Fernandez C., Hilty C., Bonjour S., Adeishvili K., Pervushin K., and Wuthrich K. Solution NMR studies of the integral membrane proteins OmpX and OmpA from Escherichia coli. FEBS Lett. 504 (2001) 173-178
19. Arora A., Abildgaard F., Bushweller J.H., and Tamm L.K. Structure of outer membrane protein A transmembrane domain by NMR spectroscopy. Nat. Struct. Biol. 8 (2001) 334-338
20. Roosild T.P., Greenwald J., Vega M., Castronovo S., Riek R., and Choe S. NMR structure of Mistic, a membrane-integrating protein for membrane protein expression. Science 307 (2005) 1317-1321
21. Oxenoid K., and Chou J.J. The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10870-10875
22. Buffy J.J., Buck-Koehntop B.A., Porcelli F., Traaseth N.J., Thomas D.D., and Veglia G. Defining the intramembrane binding mechanism of sarcolipin to calcium ATPase using solution NMR spectroscopy. J. Mol. Biol. 358 (2006) 420-429
23. Traaseth N.J., Buffy J.J., Zamoon J., and Veglia G. Structural dynamics and topology of phospholamban in oriented lipid bilayers using multidimensional solid-state NMR. Biochemistry 45 (2006) 13827-13834
24. Porcelli F., Buck B., Lee D.K., Hallock K.J., Ramamoorthy A., and Veglia G. Structure and orientation of pardaxin determined by NMR experiments in model membranes. J. Biol. Chem. 279 (2004) 45815-45823
25. Porcelli F., Buck-Koehntop B.A., Thennarasu S., Ramamoorthy A., and Veglia G. Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. Biochemistry 45 (2006) 5793-5799
26. Pervushin K., Riek R., Wider G., and Wuthrich K. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12366-12371
27. Riek R., Pervushin K., and Wuthrich K. TROSY and CRINEPT: NMR with large molecular and supramolecular structures in solution. Trends Biochem. Sci. 25 (2000) 462-468
28. Tian C., Karra M.D., Ellis C.D., Jacob J., Oxenoid K., Sonnichsen F., and Sanders C.R. Membrane protein preparation for TROSY NMR screening. Methods Enzymol. 394 (2005) 321-334
29. Tugarinov V., Sprangers R., and Kay L.E. Line narrowing in methyl-TROSY using zero-quantum 1H-13C NMR spectroscopy. J. Am. Chem. Soc. 126 (2004) 4921-4925
30. Gardner K.H., Rosen M.K., and Kay L.E. Global folds of highly deuterated, methyl-protonated proteins by multidimensional NMR. Biochemistry 36 (1997) 1389-1401
31. Tugarinov V., Kanelis V., and Kay L.E. Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy. Nat. Protoc. 1 (2006) 749-754
32. Goto N.K., Gardner K.H., Mueller G.A., Willis R.C., and Kay L.E. A robust and cost-effective method for the production of Val, Leu, Ile (delta 1) methyl-protonated 15N-, 13C-, 2H-labeled proteins. J. Biomol. NMR 13 (1999) 369-374
33. Jaroniec C.P., Kaufman J.D., Stahl S.J., Viard M., Blumenthal R., Wingfield P.T., and Bax A. Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain. Biochemistry 44 (2005) 16167-16180
34. Durr U.H., Yamamoto K., Im S.C., Waskell L., and Ramamoorthy A. Solid-state NMR reveals structural and dynamical properties of a membrane-anchored electron-carrier protein, cytochrome b5. J. Am. Chem. Soc. 129 (2007) 6670-6671
35. Dvinskikh S.V., Durr U.H., Yamamoto K., and Ramamoorthy A. High-resolution 2D NMR spectroscopy of bicelles to measure the membrane interaction of ligands. J. Am. Chem. Soc. 129 (2007) 794-802
36. Dvinskikh S.V., Yamamoto K., Durr U.H., and Ramamoorthy A. Sensitivity and resolution enhancement in solid-state NMR spectroscopy of bicelles. J. Magn. Reson. 184 (2007) 228-235
37. Samoson A., Tuherm T., and Gan Z. High-field high-speed MAS resolution enhancement in 1 H NMR spectroscopy of solids. Solid State Nucl. Magn. Reson. 20 (2001) 130-136
38. De Paepe G., Bayro M.J., Lewandowski J., and Griffin R.G. Broadband homonuclear correlation spectroscopy at high magnetic fields and MAS frequencies. J. Am. Chem. Soc. 128 (2006) 1776-1777
39. Veshtort M., and Griffin R.G. High-performance selective excitation pulses for solid- and liquid-state NMR spectroscopy. ChemPhysChem 5 (2004) 834-850
40. Baldus M. Molecular interactions investigated by multi-dimensional solid-state NMR. Curr. Opin. Struct. Biol. 16 (2006) 618-623
41. Wu C.H., Ramamoorthy A., and Opella S.J. High-resolution heteronuclear dipolar solid-state NMR-spectroscopy. J. Magn. Reson., Ser. A 109 (1994) 270-272
42. Ramamoorthy A., Wu C.H., and Opella S.J. Experimental aspects of multidimensional solid-state NMR correlation spectroscopy. J. Magn. Reson. 140 (1999) 131-140
43. Ramamoorthy A., Wei Y.F., and Lee D.K. PISEMA solid-state NMR spectroscopy. Advances in solid state NMR studies of materials and polymers: a special volume dedicated to Isao Ando vol. 52 (2004) 1-52
44. Chu-Kung A.F., Bozzelli K.N., Lockwood N.A., Haseman J.R., Mayo K.H., and Tirrell M.V. Promotion of peptide antimicrobial activity by fatty acid conjugation. Bioconjug. Chem. 15 (2004) 530-535
45. Lockwood N.A., Haseman J.R., Tirrell M.V., and Mayo K.H. Acylation of SC4 dodecapeptide increases bactericidal potency against gram-positive bacteria, including drug-resistant strains. Biochem. J. 378 (2004) 93-103
46. Wakabayashi H., Matsumoto H., Hashimoto K., Teraguchi S., Takase M., and Hayasawa H. N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob. Agents Chemother. 43 (1999) 1267-1269
47. Mak P., Pohl J., Dubin A., Reed M.S., Bowers S.E., Fallon M.T., and Shafer W.M. The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes. Int. J. Antimicrob. Agents 21 (2003) 13-19
48. Epand R.M. Biophysical studies of lipopeptide-membrane interactions. Biopolymers 43 (1997) 15-24
49. Thennarasu S., Lee D.K., Tan A., Prasad Kari U., and Ramamoorthy A. Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. Biochim. Biophys. Acta 1711 (2005) 49-58
50. Zhang L., Dhillon P., Yan H., Farmer S., and Hancock R.E.W. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44 (2000) 3317-3321
51. Hancock R.E.W., and Chapple D.S. Peptide antibiotics. Antimicrob. Agents Chemother. 43 (1999) 1317-1323
52. Storm D.R., Rosenthal K.S., and Swanson P.E. Polymyxin and related peptide antibiotics. Ann. Rev. Biochem. 46 (1977) 723-763
53. Miller I.R., Bach D., and Teuber M. Effect of polymyxin B on the structure and the stability of lipid layers. J. Membr. Biol. 39 (1978) 49-56
54. Teuber M., and Bader J. Action of polymyxin B on bacterial membranes: phosphatidylglycerol- and cardiolipin-induced susceptibility to polymyxin B in Acholeplasma laidlawii B. Antimicrob. Agents Chemother. 9 (1976) 26-35
55. Heinemann B., Kaplan M.A., Muir R.D., and Hooper I.R. Amphomycin, a new antibiotic. Antibiot. Chemother. 3 (1953) 1239-1242
56. Lomakina N.N., and Brazhnikova M.G. Chemical composition of crystallomycin. Biokhimiia 24 (1959) 425-431
57. Gol'Dberg L.E. Pharmacological investigations on the antibiotic crystallomycin. Antibiotiki 4 (1959) 63-67
58. Darken M.A., Jensen A.L., and Shu P. Aspartocin. II. Fermentation studies. Antibiot. Annu. 7 (1959) 199-204
59. Kirsch E.J., Dornbush A.C., and Backus E.J. Aspartocin. III. In vitro antimicrobial properties. Antibiot. Annu. 7 (1959) 205-212
60. Redin G.S., and Mc C.M. Aspartocin. IV. Activity against experimental infections in mice. Antibiot. Annu. 7 (1959) 213-219
61. Shay A.J., Adam J., Martin J.H., Hausmann W.K., Shu P., and Bohonos N. Aspartocin. I. Production, isolation, and characteristics. Antibiot. Annu. 7 (1959) 194-198
62. Fujino M. On glumamycin, a new antibiotic. VI. An approach to the amino acid sequence. Bull. Chem. Soc. Jpn. 38 (1965) 517-522
63. Fujino M., Inoue M., Ueyanagi J., and Miyake A. On glumamycin, a new antibiotic. V. The steric configuration of alpha, beta-diaminobutyric acid. Bull. Chem. Soc. Jpn. 38 (1965) 515-517
64. Shibata M., Kanzaki T., Nakazawa K., Inoue M., Hitomi H., Mizuno K., Fujino M., and Akira M. On glumamycin, a new antibiotic. J. Antibiot. (Tokyo) 15 (1962) 1-6
65. Naganawa H., Hamada M., Maeda K., Okami Y., and Takeushi T. Laspartomycin, a new anti-staphylococcal peptide. J. Antibiot. (Tokyo) 21 (1968) 55-62
66. Shoji J., and Otsuka H. Studies on tsushimycin. II. The structures of constituent fatty acids. J. Antibiot. (Tokyo) 22 (1969) 473-479
67. Shoji J.I., Kozuki S., Okamoto S., Sakazaki R., and Otsuka H. Studies on tsushimycin. I. Isolation and characterization of an acidic acylpeptide containing a new fatty acid. J. Antibiot. (Tokyo) 21 (1968) 439-443
68. Hodinka R.L., Jack-Wait K., Wannamaker N., Walden T.P., and Gilligan P.H. Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Eur. J. Clin. Microbiol. 6 (1987) 100-103
69. Allen N.E., Hobbs J.N., and Alborn Jr. W.E. Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032. Antimicrob. Agents Chemother. 31 (1987) 1093-1099
70. Bayer A.S., Yih J., and Hirano L. LY146032 compared with penicillin G in experimental aortic valve endocarditis caused by group G streptococci. Antimicrob. Agents Chemother. 32 (1988) 141-143
71. Botha P.L., van Heerden C.J., Vorster E., and Venter E.C. In vitro evaluation of the cyclic lipopeptide LY 146032 (daptomycin). S. Afr. Med. J. 74 (1988) 16-18
72. Ehlert F., and Neu H.C. In vitro activity of LY146032 (daptomycin), a new peptolide. Eur. J. Clin. Microbiol. 6 (1987) 84-90
73. Straus S.K., and Hancock R.E. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 1758 (2006) 1215-1223
74. Baltz R.H., Brian P., Miao V., and Wrigley S.K. Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporus. J. Ind. Microbiol. Biotech. (2005) 1-9
75. Nguyen K.T., Ritz D., Gu J.Q., Alexander D., Chu M., Miao V., Brian P., and Baltz R.H. Combinatorial biosynthesis of novel antibiotics related to daptomycin. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17462-17467
76. Grunewald J., Sieber S.A., Mahlert C., Linne U., and Marahiel M.A. Synthesis and derivatization of daptomycin: a chemoenzymatic route to acidic lipopeptide antibiotics. J. Am. Chem. Soc. 126 (2004) 17025-17031
77. Kopp F., Grunewald J., Mahlert C., and Marahiel M.A. Chemoenzymatic design of acidic lipopeptide hybrids: new insights into the structure-activity relationship of daptomycin and A54145. Biochemistry 45 (2006) 10474-10481
78. Andrew J.H., Wale M.C., Wale L.J., and Greenwood D. The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci. J. Antimicrob. Chemother. 20 (1987) 213-221
79. Chow A.W., and Cheng N. In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria. Antimicrob. Agents Chemother. 32 (1988) 788-790
80. Eliopoulos G.M., Willey S., Reiszner E., Spitzer P.G., Caputo G., and Moellering Jr. R.C. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrob. Agents Chemother. 30 (1986) 532-535
81. S.W., Ho, D., Jung, J.R., Calhoun, J.D., Lear, M., Okon, W.R.P., Scott, R.E., Hancock and S.K., Straus, Eur. Biophys. J. in press.
82. Ball L.J., Goult C.M., Donarski J.A., Micklefield J., and Ramesh V. NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin. Org. Biomol. Chem. 2 (2004) 1872-1878
83. D., Jung, J.P., Powers, S.K., Straus, R.E., Hancock, Chem. Phys. Lipids. submitted for publication.
84. Abbanat D., Macielag M., and Bush K. Novel antibacterial agents for the treatment of serious gram-positive infections. Expert Opin. Investig. Drugs 12 (2003) 379-399
85. Alder J.D. Daptomycin: a new drug class for the treatment of gram-positive infections. Drugs Today (Barc.) 41 (2005) 81-90
86. Silverman J.A., Perlmutter N.G., and Shapiro H.M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47 (2003) 2538-2544
87. Hancock R.E.W. Mechanisms of action of newer antibiotics for gram-positive pathogens. Lancet, Infect. Dis. 5 (2005) 209-218
88. Steenbergen J.N., Alder J., Thorne G.M., and Tally F.P. Daptomycin: a lipopeptide antibiotic for the treatment of serious gram-positive infections. J. Antimicrob. Chemother. 55 (2005) 283-288
89. Shah P.M. The need for new therapeutic agents: what is the pipeline?. Clin. Microbiol. Infect. 11 Suppl 3 (2005) 36-42
90. Tinoco L.W., Da Silva Jr. A., Leite A., Valente A.P., and Almeida F.C. NMR structure of PW2 bound to SDS micelles. A tryptophan-rich anticoccidial peptide selected from phage display libraries. J. Biol. Chem. 277 (2002) 36351-36356
91. Daura X., Antes I., van Gunsteren W.F., Thiel W., and Mark A.E. The effect of motional averaging on the calculation of NMR-derived structural properties. Proteins 36 (1999) 542-555
92. Garidel P., and Blume A. 1,2-Dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG) monolayers: influence of temperature, pH, ionic strength and binding of alkaline earth cations. Chem. Phys. Lipids 138 (2005) 50-59
93. Noy D., Calhoun J.R., and Lear J.D. Direct analysis of protein sedimentation equilibrium in detergent solutions without density matching. Anal. Biochem. 320 (2003) 185-192
94. Braunschweiler L., and Ernst R.R. Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J. Magn. Reson. 53 (1983) 521-528
95. Jeener J., Meier B.H., Bachmann P., and Ernst R.R. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71 (1979) 4546-4553
96. Marion D., and Wuthrich K. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113 (1983) 967-974
97. Hwang T.L., and Shaka A.J. Water suppression that works-excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson., Ser. A 112 (1995) 275-279
98. Rance M., Sorensen O., Bodenhausen G., Wagner G., Ernst R.R., and Wüthrich K. Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117 (1983) 479-485
99. Piotto M., Saudek V., and Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2 (1992) 661-665
100. van Gunsteren W.F., Billeter S.R., Eising A.A., Huenenberger P.H., Krueger P., Mark A.E., Scott W.R.P., and Tironi I.G. Biomolecular simulation: the GROMOS96 manual and user guide. VdF: Hochschulverlag AG an der ETH Zurich BIOMOS b.v., Zurich, Groningen (1996)
101. Scott W.R.P., Hunenberger P.H., Tironi I.G., Mark A.E., Billeter S.R., Fennen J., Torda A.E., Huber T., Kruger P., and van Gunsteren W.F. The GROMOS biomolecular simulation program package. J. Phys. Chem., A Mol. Spectrosc. Kinet. Environ. Gen. Theory 103 (1999) 3596-3607
102. Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., and Hermans J. In: Pullman B. (Ed). Intermolecular Forces (1981), Reidel, Dordrecht 331-342
103. Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., Dinola A., and Haak J.R. Molecular-dynamics with coupling to an external bath. J. Chem. Phys. 81 (1984) 3684-3690
104. Ryckaert J.P., Ciccotti G., and Berendsen H.J.C. Numerical-Integration of cartesian equations of motion of a system with constraints - molecular-dynamics of n-alkanes. J. Comput. Phys. 23 (1977) 327-341
105. Tironi I.G., Sperb R., Smith P.E., and van Gunsteren W.F. A generalized reaction field method for molecular-dynamics simulations. J. Chem. Phys. 102 (1995) 5451-5459
106. Torda A.E., Scheek R.M., and van Gunsteren W.F. Time-dependent distance restraints in molecular-dynamics simulations. Chem. Phys. Lett. 157 (1989) 289-294
107. Matsuzaki K., Murase O., Fugii N., and Miyajima K. An antimicrobial peptide, Magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 35 (1996) 11361-11368
108. Zhang L., Rozek A., and Hancock R.E.W. Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 276 (2001) 35714-35722
109. Bodner M.L., Gabrys C.M., Parkanzky P.D., Yang J., Duskin C.A., and Weliky D.P. Temperature dependence and resonance assignment of 13C NMR spectra of selectively and uniformly labeled fusion peptides associated with membranes. Magn. Reson. Chem. 42 (2004) 187-194
110. Qiang W., Yang J., and Weliky D.P. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide to lipid distances reveal the intimate contact of beta strand peptide with membranes and the proximity of the Ala-14-Gly-16 region with lipid headgroups. Biochemistry 46 (2007) 4997-5008
111. Wasniewski C.M., Parkanzky P.D., Bodner M.L., and Weliky D.P. Solid-state nuclear magnetic resonance studies of HIV and influenza fusion peptide orientations in membrane bilayers using stacked glass plate samples. Chem. Phys. Lipids 132 (2004) 89-100
112. Yang J., Gabrys C.M., and Weliky D.P. Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide. Biochemistry 40 (2001) 8126-8137
113. Yang J., Parkanzky P.D., Bodner M.L., Duskin C.A., and Weliky D.P. Application of REDOR subtraction for filtered MAS observation of labeled backbone carbons of membrane-bound fusion peptides. J. Magn. Reson. 159 (2002) 101-110
114. Yang J., Parkanzky P.D., Khunte B.A., Canlas C.G., Yang R., Gabrys C.M., and Weliky D.P. Solid state NMR measurements of conformation and conformational distributions in the membrane-bound HIV-1 fusion peptide. J. Mol. Graph. Model 19 (2001) 129-135
115. Yang J., Prorok M., Castellino F.J., and Weliky D.P. Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers. Biophys. J. 87 (2004) 1951-1963
116. Yang J., and Weliky D.P. Solid-state nuclear magnetic resonance evidence for parallel and antiparallel strand arrangements in the membrane-associated HIV-1 fusion peptide. Biochemistry 42 (2003) 11879-11890
117. Yang R., Prorok M., Castellino F.J., and Weliky D.P. A trimeric HIV-1 fusion peptide construct which does not self-associate in aqueous solution and which has 15-fold higher membrane fusion rate. J. Am. Chem. Soc. 126 (2004) 14722-14723
118. Yang R., Yang J., and Weliky D.P. Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides. Biochemistry 42 (2003) 3527-3535
119. Zheng Z., Yang R., Bodner M.L., and Weliky D.P. Conformational flexibility and strand arrangements of the membrane-associated HIV fusion peptide trimer probed by solid-state NMR spectroscopy. Biochemistry 45 (2006) 12960-12975
120. Hong M. Oligomeric structure, dynamics, and orientation of membrane proteins from solid-state NMR. Structure 14 (2006) 1731-1740
121. Luo W., and Hong M. Determination of the oligomeric number and intermolecular distances of membrane protein assemblies by anisotropic 1H-driven spin diffusion NMR spectroscopy. J. Am. Chem. Soc. 128 (2006) 7242-7251